BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 4860298)

  • 1. Cyclazocine in the treatment of narcotic addiction.
    Jaffe JH
    Curr Psychiatr Ther; 1967; 7():147-56. PubMed ID: 4860298
    [No Abstract]   [Full Text] [Related]  

  • 2. Narcotic antagonists in the treatment of opiate dependence.
    Fink M; Zaks A; Resnick RB; Freedman AM
    Int Z Klin Pharmakol Ther Toxikol; 1971 Jun; 4(4):455-8. PubMed ID: 5566728
    [No Abstract]   [Full Text] [Related]  

  • 3. Synthetic 14-hydroxymorphinan narcotic antagonists.
    Pachter IJ
    Adv Biochem Psychopharmacol; 1973; 8(0):57-62. PubMed ID: 4153098
    [No Abstract]   [Full Text] [Related]  

  • 4. [Management of opium addicts using opiates and their antagonists].
    Burchard JM
    Nervenarzt; 1972 Oct; 43(10):501-4. PubMed ID: 4564819
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacological approaches to the treatment of morphine-type dependence.
    Halbach H
    Int J Clin Pharmacol Biopharm; 1975 Jul; 12(1-2):6-12. PubMed ID: 1165143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Narcotic antagonists. Treatment tool for addiction.
    Valentine NM; Meyer RE
    Nurs Clin North Am; 1976 Sep; 11(3):541-9. PubMed ID: 785400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacologic aspects of the treatment of drug addiction due to morphine-like substances].
    Babaian EA; Bulaev VM
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1989; 89(1):134-9. PubMed ID: 2566216
    [No Abstract]   [Full Text] [Related]  

  • 8. Cyclazocine revisited.
    Archer S; Glick SD; Bidlack JM
    Neurochem Res; 1996 Nov; 21(11):1369-73. PubMed ID: 8947927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous diacetylmorphine (heroin) in studies of opiate dependence.
    Zaks AM; Bruner A; Fink M; Freedman AM
    Dis Nerv Syst; 1969 Feb; 30(2):Suppl:89-92. PubMed ID: 4886996
    [No Abstract]   [Full Text] [Related]  

  • 10. Addiction and the community. (Narcotic substitution therapy).
    Taylor WJ; Chambers CD; Bowling CE
    Int J Clin Pharmacol; 1972 Apr; 6(1):28-39. PubMed ID: 4625924
    [No Abstract]   [Full Text] [Related]  

  • 11. Naltrexone, an antagonist for the treatment of heroin dependence. Effects in man.
    Martin WR; Jasinski DR; Mansky PA
    Arch Gen Psychiatry; 1973 Jun; 28(6):784-91. PubMed ID: 4707988
    [No Abstract]   [Full Text] [Related]  

  • 12. [The effect of GABA-positive agents on the formation of morphine dependence and on the manifestations of a withdrawal syndrome].
    Belozertseva IV; Andreev BV
    Eksp Klin Farmakol; 2000; 63(1):19-23. PubMed ID: 10763104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclazocine and methadone in narcotic addiction.
    Freedman AM; Fink M; Sharoff R; Zaks A
    JAMA; 1967 Oct; 202(3):191-4. PubMed ID: 6072354
    [No Abstract]   [Full Text] [Related]  

  • 14. Basic concepts and use of cyclazocine in the treatment of narcotic addiction.
    Freedman AM; Fink M
    Br J Addict Alcohol Other Drugs; 1968 Sep; 63(1):59-69. PubMed ID: 5245946
    [No Abstract]   [Full Text] [Related]  

  • 15. The relationship between the acute behavioral effects of narcotic antagonists and the narcotic-dependent state [proceedings].
    Valentino RJ; Herling S; Woods JH
    Psychopharmacol Bull; 1981 Jan; 17(1):51-4. PubMed ID: 7195052
    [No Abstract]   [Full Text] [Related]  

  • 16. Narcotic antagonists of the 4-phenylpiperidine series.
    Langbein A; Merz H; Stockhaus K; Wick H
    Adv Biochem Psychopharmacol; 1973; 8(0):157-65. PubMed ID: 4212187
    [No Abstract]   [Full Text] [Related]  

  • 17. The use of cyclazocine in the treatment of heroin addicts.
    Petursson ES; Preble E
    Dis Nerv Syst; 1970 Aug; 31(8):549-51. PubMed ID: 5471792
    [No Abstract]   [Full Text] [Related]  

  • 18. The use of drugs in the management of drug dependence.
    Eddy NB
    J Tenn Med Assoc; 1967 Mar; 60(3):269-73. PubMed ID: 6042204
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical studies of cyclazocine in the treatment of narcotic addiction.
    Freedman AM; Fink M; Sharoff R; Zaks A
    Am J Psychiatry; 1968 May; 124(11):1499-504. PubMed ID: 4869436
    [No Abstract]   [Full Text] [Related]  

  • 20. Novel depots of buprenorphine have a long-acting effect for the management of physical dependence to morphine.
    Liu KS; Kao CH; Liu SY; Sung KC; Kuei CH; Wang JJ
    J Pharm Pharmacol; 2006 Mar; 58(3):337-44. PubMed ID: 16536900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.